Literature DB >> 21478671

Thrombopoietin and hematopoietic stem cells.

Carolyn A de Graaf1, Donald Metcalf.   

Abstract

Thrombopoietin (TPO) is the cytokine that is chiefly responsible for megakaryocyte production but increasingly attention has turned to its role in maintaining hematopoietic stem cells (HSCs). HSCs are required to initiate the production of all mature hematopoietic cells, but this differentiation needs to be balanced against self-renewal and quiescence to maintain the stem cell pool throughout life. TPO has been shown to support HSC quiescence during adult hematopoiesis, with the loss of TPO signaling associated with bone marrow failure and thrombocytopenia. Recent studies have shown that constitutive activation mutations in Mpl contribute to myeloproliferative disease. In this review, we will discuss TPO signaling pathways, regulation of TPO levels and the role of TPO in normal hematopoiesis and during myeloproliferative disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21478671      PMCID: PMC3127159          DOI: 10.4161/cc.10.10.15619

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  114 in total

1.  X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoiesis.

Authors:  Ross L Levine; Claude Belisle; Martha Wadleigh; David Zahrieh; Stephanie Lee; Pierre Chagnon; D Gary Gilliland; Lambert Busque
Journal:  Blood       Date:  2006-01-24       Impact factor: 22.113

2.  Molecular mimicry in the chronic myeloproliferative disorders: reciprocity between quantitative JAK2 V617F and Mpl expression.

Authors:  Alison R Moliterno; Donna M Williams; Ophelia Rogers; Jerry L Spivak
Journal:  Blood       Date:  2006-08-15       Impact factor: 22.113

3.  AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP.

Authors:  James B Bussel; David J Kuter; James N George; Robert McMillan; Louis M Aledort; George T Conklin; Alan E Lichtin; Roger M Lyons; Jorge Nieva; Jeffrey S Wasser; Israel Wiznitzer; Reggie Kelly; Chien-Feng Chen; Janet L Nichol
Journal:  N Engl J Med       Date:  2006-10-19       Impact factor: 91.245

Review 4.  The hematopoietic stem cell in its place.

Authors:  Gregor B Adams; David T Scadden
Journal:  Nat Immunol       Date:  2006-04       Impact factor: 25.606

5.  Studies of c-Mpl function distinguish the replication of hematopoietic stem cells from the expansion of differentiating clones.

Authors:  Janis L Abkowitz; Jing Chen
Journal:  Blood       Date:  2007-03-08       Impact factor: 22.113

6.  Cytokines regulate postnatal hematopoietic stem cell expansion: opposing roles of thrombopoietin and LNK.

Authors:  Natalija Buza-Vidas; Jennifer Antonchuk; Hong Qian; Robert Månsson; Sidinh Luc; Sasan Zandi; Kristina Anderson; Satoshi Takaki; Jens M Nygren; Christina T Jensen; Sten Eirik W Jacobsen
Journal:  Genes Dev       Date:  2006-08-01       Impact factor: 11.361

Review 7.  The JAK-STAT signaling pathway: input and output integration.

Authors:  Peter J Murray
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

8.  MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients.

Authors:  Animesh D Pardanani; Ross L Levine; Terra Lasho; Yana Pikman; Ruben A Mesa; Martha Wadleigh; David P Steensma; Michelle A Elliott; Alexandra P Wolanskyj; William J Hogan; Rebecca F McClure; Mark R Litzow; D Gary Gilliland; Ayalew Tefferi
Journal:  Blood       Date:  2006-07-25       Impact factor: 22.113

9.  Dual role of Mpl receptor during the establishment of definitive hematopoiesis.

Authors:  Laurence Petit-Cocault; Cécile Volle-Challier; Maud Fleury; Bruno Péault; Michèle Souyri
Journal:  Development       Date:  2007-07-18       Impact factor: 6.868

10.  MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.

Authors:  Yana Pikman; Benjamin H Lee; Thomas Mercher; Elizabeth McDowell; Benjamin L Ebert; Maricel Gozo; Adam Cuker; Gerlinde Wernig; Sandra Moore; Ilene Galinsky; Daniel J DeAngelo; Jennifer J Clark; Stephanie J Lee; Todd R Golub; Martha Wadleigh; D Gary Gilliland; Ross L Levine
Journal:  PLoS Med       Date:  2006-07       Impact factor: 11.069

View more
  46 in total

1.  Somatic thrombopoietin (THPO) gene mutations in childhood myeloid leukemias.

Authors:  Maite E Houwing; Eva A Koopman-Coenen; Rogier Kersseboom; Saskia Gooskens; Inge M Appel; Susan T C J M Arentsen-Peters; Andrica C H de Vries; Dirk Reinhardt; Jan Stary; André Baruchel; Valerie de Haas; Marjolein Blink; Rob H Lopes Cardozo; Rob Pieters; C Michel Zwaan; Marry M van den Heuvel-Eibrink
Journal:  Int J Hematol       Date:  2015-03-03       Impact factor: 2.490

Review 2.  Optimizing autologous cell grafts to improve stem cell gene therapy.

Authors:  Nikoletta Psatha; Garyfalia Karponi; Evangelia Yannaki
Journal:  Exp Hematol       Date:  2016-04-19       Impact factor: 3.084

Review 3.  Cell cycle regulation of hematopoietic stem or progenitor cells.

Authors:  Sha Hao; Chen Chen; Tao Cheng
Journal:  Int J Hematol       Date:  2016-03-23       Impact factor: 2.490

Review 4.  Modeling Human Bone Marrow Failure Syndromes Using Pluripotent Stem Cells and Genome Engineering.

Authors:  Moonjung Jung; Cynthia E Dunbar; Thomas Winkler
Journal:  Mol Ther       Date:  2015-10-05       Impact factor: 11.454

5.  Identification of a new Mpl-interacting protein, Atp5d.

Authors:  Hongyan Liu; Zhenhu Zhao; Yuxu Zhong; Yajun Shan; Xiaohong Sun; Bingzhi Mao; Yuwen Cong
Journal:  Mol Cell Biochem       Date:  2014-03-11       Impact factor: 3.396

6.  Megakaryocyte and Osteoblast Interactions Modulate Bone Mass and Hematopoiesis.

Authors:  Marta B Alvarez; LinLin Xu; Paul J Childress; Kevin A Maupin; Safa F Mohamad; Brahmananda R Chitteti; Evan Himes; David J Olivos; Ying-Hua Cheng; Simon J Conway; Edward F Srour; Melissa A Kacena
Journal:  Stem Cells Dev       Date:  2018-05-15       Impact factor: 3.272

7.  Nfix Promotes Survival of Immature Hematopoietic Cells via Regulation of c-Mpl.

Authors:  Trent Hall; Megan Walker; Miguel Ganuza; Per Holmfeldt; Marie Bordas; Guolian Kang; Wenjian Bi; Lance E Palmer; David Finkelstein; Shannon McKinney-Freeman
Journal:  Stem Cells       Date:  2018-02-27       Impact factor: 6.277

8.  rBPI21 (Opebacan) Promotes Rapid Trilineage Hematopoietic Recovery in a Murine Model of High-Dose Total Body Irradiation.

Authors:  Kenneth J Janec; Huaiping Yuan; James E Norton; Rowan H Kelner; Christian K Hirt; Rebecca A Betensky; Eva C Guinan
Journal:  Am J Hematol       Date:  2018-05-11       Impact factor: 10.047

9.  The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling.

Authors:  Renata Grozovsky; Antonija Jurak Begonja; Kaifeng Liu; Gary Visner; John H Hartwig; Hervé Falet; Karin M Hoffmeister
Journal:  Nat Med       Date:  2014-12-08       Impact factor: 53.440

Review 10.  Haematopoietic stem cell self-renewal in vivo and ex vivo.

Authors:  Adam C Wilkinson; Kyomi J Igarashi; Hiromitsu Nakauchi
Journal:  Nat Rev Genet       Date:  2020-05-28       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.